Nangaku, Masaomi

Chronic kidney disease and the global public health agenda: an international consensus

Francis, A., Harhay, M. N., Ong, A. C. M., Tummalapalli, S. L., Ortiz, A., Fogo, A. B., Fliser, D., Roy-Chaudhury, P., Fontana, M., Nangaku, M., et al. (2024) · Nature Reviews Nephrology

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 1,374

Mitochondrial Damage Causes Inflammation via cGAS-STING Signaling in Acute Kidney Injury

Maekawa, H., Inoue, T., Ouchi, H., Jao, T.-M., Inoue, R., Nishi, H., Fujii, R., Ishidate, F., Tanaka, T., Tanaka, Y., et al. (2019) · Cell Reports

Acute Kidney Injury Researchinterferon and immune responses

Cited by 586

Finerenone with empagliflozin in chronic kidney disease and type 2 diabetes

Agarwal, R., Green, J. B., Heerspink, H. J. L., Mann, J. F. E., McGill, J. B., Mottl, A. K., Rosenstock, J., Rossing, P., Vaduganathan, M., Brinker, M., et al. (2025) · New England Journal of Medicine

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 319

Dynamic Change of Chromatin Conformation in Response to Hypoxia Enhances the Expression of GLUT3 (SLC2A3) by Cooperative Interaction of Hypoxia-Inducible Factor 1 and KDM3A

Mimura, I., Nangaku, M., Kanki, Y., Tsutsumi, S., Inoue, T., Kohro, T., Yamamoto, S., Fujita, T., Shimamura, T., Suehiro, J.-I., et al. (2012) · Molecular and Cellular Biology

Cancer, Hypoxia, and MetabolismGenomics and Chromatin Dynamics

Cited by 251

Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial

Ito, S., Kashihara, N., Shikata, K., Nangaku, M., Wada, T., Okuda, Y., & Sawanobori, T. (2020) · Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 234

Renal catabolism of advanced glycation end products: the fate of pentosidine

Miyata, T., Ueda, Y., Horie, K., Nangaku, M., Tanaka, S., de Strihou, C. V. Y., & Kurokawa, K. (1998) · Kidney International

Advanced Glycation End Products researchChronic Kidney Disease and Diabetes

Cited by 227

International consensus definitions of clinical trial outcomes for kidney failure: 2020

Levin, A., Agarwal, R., Herrington, W. G., Heerspink, H. L., Mann, J. F. E., Shahinfar, S., Tuttle, K. R., Donner, J.-A., Jha, V., Nangaku, M., et al. (2020) · Kidney International

Chronic Kidney Disease and DiabetesStatistical Methods in Clinical Trials

Cited by 125

Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial

Ito, S., Shikata, K., Nangaku, M., Okuda, Y., & Sawanobori, T. (2019) · Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 107

Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes

Ueki, K., Sasako, T., Okazaki, Y., Miyake, K., Nangaku, M., Ohashi, Y., Noda, M., & Kadowaki, T. (2021) · Kidney International

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 94

Erythropoietin induces heme oxygenase-1 expression and attenuates oxidative stress

Katavetin, P., Inagi, R., Miyata, T., Shao, J., Sassa, R., Adler, S., Eto, N., Kato, H., Fujita, T., & Nangaku, M. (2007) · Biochemical and Biophysical Research Communications

Heme Oxygenase-1 and Carbon MonoxideErythropoietin and Anemia Treatment

Cited by 84

Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney

MIYATA, T., SUGIYAMA, S., NANGAKU, M., SUZUKI, D., URAGAMI, K.-I., INAGI, R., SAKAI, H., & KUROKAWA, K. (1999) · Journal of the American Society of Nephrology

Renal Diseases and GlomerulopathiesChronic Kidney Disease and Diabetes

Cited by 55

Anthracycline Inhibits Recruitment of Hypoxia-inducible Transcription Factors and Suppresses Tumor Cell Migration and Cardiac Angiogenic Response in the Host

Tanaka, T., Yamaguchi, J., Shoji, K., & Nangaku, M. (2012) · Journal of Biological Chemistry

Cancer, Hypoxia, and MetabolismChemotherapy-induced cardiotoxicity and mitigation

Cited by 50

Wrong Primer for Rat Angiotensinogen mRNA

Katavetin, P., Nangaku, M., & Fujita, T. (2005) · American Journal of Physiology-Renal Physiology

Renin-Angiotensin System StudiesMolecular Biology Techniques and Applications

Cited by 4

Multi-Agent Dynamic Refinement Outperforms Static RAG in Clinical Reasoning for Complex Nephrology Cases

Yano, Y., Kakizaki, H., Nagasu, H., Kishi, S., Koshida, T., Nihei, Y., Hirano, A., Sugawara, Y., Imaizumi, T., Osakabe, Y., et al. (2026) · medRxiv

Artificial Intelligence in Healthcare and EducationClinical Reasoning and Diagnostic Skills

Cited by 0